Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
The price of BioNTech SE ADR (NASDAQ: BNTX) closed at $121.16 in the last session, down -2.53% from day before closing price of $124.30. In other words, the price has decreased by -$2.53 from its previous closing price. On the day, 0.62 million shares were traded. BNTX stock price reached its highest trading level at $126.77 during the session, while it also had its lowest trading level at $119.32.
Ratios:
We take a closer look at BNTX’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 1.56 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 19.65. For the most recent quarter (mrq), Quick Ratio is recorded 7.21 and its Current Ratio is at 7.33. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Truist on January 10, 2025, initiated with a Buy rating and assigned the stock a target price of $172.
On December 11, 2024, Wells Fargo started tracking the stock assigning a Overweight rating and target price of $170.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Dec 13 ’24 when ATHOS KG bought 4,983 shares for $120.69 per share.
ATHOS KG bought 22,450 shares of BNTX for $2,623,283 on Dec 11 ’24. On Dec 09 ’24, another insider, ATHOS KG, who serves as the 10% Owner of the company, bought 53,716 shares for $121.72 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BNTX now has a Market Capitalization of 29046898688 and an Enterprise Value of 12581268480. For the stock, the TTM Price-to-Sale (P/S) ratio is 8.80 while its Price-to-Book (P/B) ratio in mrq is 1.36. Its current Enterprise Value per Revenue stands at 4.138 whereas that against EBITDA is -45.833.
Stock Price History:
The Beta on a monthly basis for BNTX is 0.17, which has changed by 0.31520474 over the last 52 weeks, in comparison to a change of 0.23095727 over the same period for the S&P500. Over the past 52 weeks, BNTX has reached a high of $131.49, while it has fallen to a 52-week low of $76.53. The 50-Day Moving Average of the stock is 4.91%, while the 200-Day Moving Average is calculated to be 19.60%.
Shares Statistics:
According to the various share statistics, BNTX traded on average about 836.87K shares per day over the past 3-months and 667510 shares per day over the past 10 days. A total of 239.74M shares are outstanding, with a floating share count of 239.44M. Insiders hold about 0.13% of the company’s shares, while institutions hold 19.56% stake in the company. Shares short for BNTX as of 1736899200 were 2642082 with a Short Ratio of 3.16, compared to 1734048000 on 2327232. Therefore, it implies a Short% of Shares Outstanding of 2642082 and a Short% of Float of 5.29.
